BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35222556)

  • 1. Early detection of Pre-XDR TB with line probe assay in a high TB burden country.
    Madukaji L; Okohu I; Usman S; Oyedum U; Enagi A; Usman A; Adedeji AS; Owolagba F; Ofuche E; Samuels JO; Jolayemi T; Okonkwo P
    Afr Health Sci; 2021 Sep; 21(3):968-974. PubMed ID: 35222556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients.
    Elion Assiana DO; Abdul JBPA; Linguissi LSG; Epola M; Vouvoungui JC; Mabiala A; Biyogho CM; Ronald Edoa J; Adegbite BR; Adegnika AA; Elton L; Canseco JO; McHugh TD; Ahombo G; Ntoumi F
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):84. PubMed ID: 34920727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.
    Mani V; Wang S; Inci F; De Libero G; Singhal A; Demirci U
    Adv Drug Deliv Rev; 2014 Nov; 78():105-17. PubMed ID: 24882226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High correlation of clinical criteria in the diagnosis of drug-resistant TB and prevalence of ofloxacin resistance.
    Kumar R; Garg R; Kant S; Verma SK; Kushwaha RA; Kumar S; Jain A
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1354-1357. PubMed ID: 27725047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
    PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns and genetic mutations.
    Noorizhab MNF; Zainal Abidin N; Teh LK; Tang TH; Onyejepu N; Kunle-Ope C; Tochukwu NE; Sheshi MA; Nwafor T; Akinwale OP; Ismail AI; Nor NM; Salleh MZ
    Tuberculosis (Edinb); 2023 May; 140():102343. PubMed ID: 37080082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.
    Sy KTL; Leavitt SV; de Vos M; Dolby T; Bor J; Horsburgh CR; Warren RM; Streicher EM; Jenkins HE; Jacobson KR
    Sci Rep; 2022 Jun; 12(1):10844. PubMed ID: 35760977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa.
    Olawoye IB; Uwanibe JN; Kunle-Ope CN; Davies-Bolorunduro OF; Abiodun TA; Audu RA; Salako BL; Happi CT
    Sci Rep; 2021 Aug; 11(1):17387. PubMed ID: 34462504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.